| Literature DB >> 26399210 |
H Kanyerere1, A Mganga2, A D Harries3, K Tayler-Smith4, A Jahn5, F M Chimbwandira2, J Mpunga1.
Abstract
From 2000 to 2012, Malawi scaled up antiretroviral therapy (ART) from <3000 to 404 905 persons living with HIV/AIDS (human immunodeficiency virus/acquired immune-deficiency syndrome), representing an ART coverage of 40.6% among those living with HIV. During this time, annual tuberculosis (TB) notifications declined by 28%, from 28 234 to 20 463. Percentage declines in annual TB case notifications were as follows: new TB (26%), recurrent TB (40%), new smear-positive pulmonary TB (19%), new smear-negative pulmonary TB (42%), extra-pulmonary TB (19%), HIV-positive TB (30%) and HIV-negative TB (10%). The decline in TB notifications is associated with ART scale-up, supporting its value in controlling TB in high HIV prevalence areas in sub-Saharan Africa.Entities:
Keywords: ART; HIV/AIDS; Malawi; TB; recurrent TB
Year: 2014 PMID: 26399210 PMCID: PMC4539031 DOI: 10.5588/pha.14.0018
Source DB: PubMed Journal: Public Health Action ISSN: 2220-8372